Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,334 warrant series at 1,058 companies. 777 in the money, 58 expiring in the next 30 days, 39 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| January 2025 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| January 2025 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| June 2025 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| June 2025 Offering Investor | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| May 2023 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| May 2023 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| November 2024 Offering Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| November 2024 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| October 2025 Offering Investor | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| October 2025 Placement Agent | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| September 2019 Offering Investors | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| September 2019 Offering Underwriter | $0.5188 | $14.2M | 10-Q, Aug 14, 2026Dilution tabAs of Sep 25, 2026 | ||||||||
| Murano Warrants (former HCM Acquisition Corp. warrants, MRNOW) | $0.1840 | $14.2M | F-1, Jun 23, 2025Dilution tabAs of Oct 4, 2026 | ||||||||
| Exact Sciences / Genomic Health 2023 Warrants (Second APA Amendment, issued June 20, 2024) | $0.1490 | $14.2M | F-3, Jun 28, 2024Dilution tabAs of Nov 13, 2026 | ||||||||
| Exact Sciences 2026 Warrants (Fourth APA Amendment, January 9, 2026) | $0.1490 | $14.2M | 20-F, Apr 3, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| OrbiMed Warrants (Credit Agreement, issued June 20, 2024) | $0.1490 | $14.2M | 20-F, Apr 3, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Private Placement Warrants, $11.50 exercise price, expiring January 24, 2028 | $0.1900 | $14.2M | 10-Q, Aug 6, 2026Dilution tabAs of Oct 27, 2026 | ||||||||
| Public Warrants (BAERW), $11.50 exercise price, expiring January 24, 2028 | $0.1900 | $14.2M | 10-Q, Aug 6, 2026Dilution tabAs of Oct 27, 2026 | ||||||||
| Equity Financing Warrant (Streeterville Capital, LLC; issued at direct-listing closing) | $0.4099 | $14.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Second Debt Financing Warrant (issued with October 30, 2025 secured convertible note) | $0.4099 | $14.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Third Debt Financing Warrant (issued with December 19, 2025 secured convertible note) | $0.4099 | $14.2M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| August 2026 Common Warrants (Armistice / Sole Investor) – $1.65 | $0.9800 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| August 2026 Pre-Funded Warrants (Armistice / Sole Investor) – $0.00001 | $0.9800 | $14.1M | S-3/A, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| February 2025 SPA Warrants (Merchant Adventure Fund L.P.) – $5.568 | $0.9800 | $14.1M | S-3, Sep 17, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| January 2025 SPA Common Warrants (Chutzpah Holdings Limited) – $5.568 | $0.9800 | $14.1M | S-3, Sep 17, 2025Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 SPA Second Common Warrants – first closing (CHLP) – $4.25 | $0.9800 | $14.1M | SCHEDULE 13D/A, Oct 27, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| March 2026 SPA Second Common Warrants – second closing (CHLP) – $4.25 | $0.9800 | $14.1M | SCHEDULE 13D/A, Oct 27, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2026 CHLP Common Warrant (October 2026 SPA) – $1.65 | $0.9800 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 27, 2026 Purchase Agreement Common Warrants (two Purchasers) – $1.30 | $0.9800 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2024 WTI Warrants | $0.1342 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| 2025 WTI Warrants | $0.1342 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Private Placement Warrants | $0.1342 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Public Warrants | $0.1342 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series A Warrants | $0.1342 | $14.1M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Series D Preferred Stock Warrants (February 2026) | $1.51 | $14.0M | 10-K, Mar 27, 2026Dilution tabAs of Oct 24, 2026 | ||||||||
| Tranche A Warrants (Oaktree credit facility, issued April 27, 2023) | $1.41 | $14.0M | 8-K EX-4.1, Apr 27, 2023Dilution tabAs of Nov 4, 2026 | ||||||||
| Series A Warrants (Private Placement Warrants) – December 2024 Private Placement | $0.8366 | $13.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Series B Warrants (Pre-Funded Warrants) – December 2024 Private Placement | $0.8366 | $13.9M | 10-Q, Nov 16, 2026Dilution tabAs of Nov 17, 2026 | ||||||||
| Underwriter Warrants (IPO, Maxim) – $4.80, 64,000 Ordinary Shares | $1.00 | $13.8M | F-1, Nov 2, 2026Dilution tabAs of Nov 11, 2026 | ||||||||
| Class A Common Stock (Underwriter Warrants) – November 2024 public offering | $0.4260 | $13.6M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A Common Stock warrants (previously Series m-3 Preferred Stock) | $0.4260 | $13.6M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| Class A Common Stock warrants (previously Series S Preferred Stock) | $0.4260 | $13.6M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 | ||||||||
| October 2026 Private Note Warrants — $11.50 | $0.2430 | $13.6M | 10-Q, Oct 22, 2026Dilution tabAs of Oct 27, 2026 | ||||||||
| Private Placement Warrants (from 505,000 Private Placement Units) — $11.50 | $0.2430 | $13.6M | 10-K, Sep 28, 2026Dilution tabAs of Oct 27, 2026 | ||||||||
| Public Warrants (IPO units, EONR.WS) — $11.50 per whole share | $0.2430 | $13.6M | S-1/A, Oct 27, 2026Dilution tabAs of Oct 27, 2026 | ||||||||
| Representative's Warrants (IPO firm shares) — Network 1 Financial Securities, Inc., $5.00, issued 2025-06-13 | $0.4420 | $13.6M | 20-F, Jul 27, 2026Dilution tabAs of Oct 12, 2026 | ||||||||
| Representative's Warrants (over-allotment shares) — Network 1 and affiliates, $5.00, issued 2025-06-18 | $0.4420 | $13.6M | 20-F, Jul 27, 2026Dilution tabAs of Oct 12, 2026 | ||||||||
| Assumed Heliogen SPAC Private Warrants (former Athena Technology Acquisition Corp. private placement warrants) | $0.2140 | $13.5M | S-1, Oct 28, 2025Dilution tabAs of Oct 24, 2026 | ||||||||
| Assumed Heliogen SPAC Public Warrants (former Athena Technology Acquisition Corp. public warrants) | $0.2140 | $13.5M | S-1, Oct 28, 2025Dilution tabAs of Oct 24, 2026 | ||||||||
| Public Warrants (ESGEN IPO warrants, Nasdaq: ZEOWW) | $0.2140 | $13.5M | 10-K, Apr 1, 2026Dilution tabAs of Oct 24, 2026 |
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
January 2025 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
January 2025 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
June 2025 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
June 2025 Offering Investor
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
May 2023 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
May 2023 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
November 2024 Offering Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
November 2024 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
October 2025 Offering Investor
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
October 2025 Placement Agent
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
September 2019 Offering Investors
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
CTXRCitius Pharmaceuticals, Inc.$0.5188Last price
September 2019 Offering Underwriter
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
MRNOMurano Global Investments PLC Ordinary Shares$0.1840Last price
Murano Warrants (former HCM Acquisition Corp. warrants, MRNOW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
MDXHMDxHealth SA Ordinary Shares$0.1490Last price
Exact Sciences / Genomic Health 2023 Warrants (Second APA Amendment, issued June 20, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
MDXHMDxHealth SA Ordinary Shares$0.1490Last price
Exact Sciences 2026 Warrants (Fourth APA Amendment, January 9, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
MDXHMDxHealth SA Ordinary Shares$0.1490Last price
OrbiMed Warrants (Credit Agreement, issued June 20, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
BAERBridger Aerospace Group Holdings, Inc. Common Stock$0.1900Last price
Private Placement Warrants, $11.50 exercise price, expiring January 24, 2028
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
BAERBridger Aerospace Group Holdings, Inc. Common Stock$0.1900Last price
Public Warrants (BAERW), $11.50 exercise price, expiring January 24, 2028
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
VTIXVirtuix Holdings Inc. Class A Common Stock$0.4099Last price
Equity Financing Warrant (Streeterville Capital, LLC; issued at direct-listing closing)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
VTIXVirtuix Holdings Inc. Class A Common Stock$0.4099Last price
Second Debt Financing Warrant (issued with October 30, 2025 secured convertible note)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
VTIXVirtuix Holdings Inc. Class A Common Stock$0.4099Last price
Third Debt Financing Warrant (issued with December 19, 2025 secured convertible note)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.2M
PLURPluri Inc. Common Stock$0.9800Last price
August 2026 Common Warrants (Armistice / Sole Investor) – $1.65
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
August 2026 Pre-Funded Warrants (Armistice / Sole Investor) – $0.00001
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
February 2025 SPA Warrants (Merchant Adventure Fund L.P.) – $5.568
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
January 2025 SPA Common Warrants (Chutzpah Holdings Limited) – $5.568
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
March 2026 SPA Second Common Warrants – first closing (CHLP) – $4.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
March 2026 SPA Second Common Warrants – second closing (CHLP) – $4.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
October 2026 CHLP Common Warrant (October 2026 SPA) – $1.65
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PLURPluri Inc. Common Stock$0.9800Last price
October 27, 2026 Purchase Agreement Common Warrants (two Purchasers) – $1.30
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
INVInnventure, Inc.$0.1342Last price
2024 WTI Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
INVInnventure, Inc.$0.1342Last price
2025 WTI Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
INVInnventure, Inc.$0.1342Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
INVInnventure, Inc.$0.1342Last price
Public Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
INVInnventure, Inc.$0.1342Last price
Series A Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.1M
PAVMPAVmed Inc.$1.51Last price
Series D Preferred Stock Warrants (February 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.0M
MCRBSeres Therapeutics, Inc.$1.41Last price
Tranche A Warrants (Oaktree credit facility, issued April 27, 2023)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$14.0M
MRKRMarker Therapeutics, Inc.$0.8366Last price
Series A Warrants (Private Placement Warrants) – December 2024 Private Placement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.9M
MRKRMarker Therapeutics, Inc.$0.8366Last price
Series B Warrants (Pre-Funded Warrants) – December 2024 Private Placement
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.9M
ELOGEastern International Ltd. Ordinary Shares$1.00Last price
Underwriter Warrants (IPO, Maxim) – $4.80, 64,000 Ordinary Shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.8M
KSCPKnightscope, Inc.$0.4260Last price
Class A Common Stock (Underwriter Warrants) – November 2024 public offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
KSCPKnightscope, Inc.$0.4260Last price
Class A Common Stock warrants (previously Series m-3 Preferred Stock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
KSCPKnightscope, Inc.$0.4260Last price
Class A Common Stock warrants (previously Series S Preferred Stock)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
EONREON Resources Inc$0.2430Last price
October 2026 Private Note Warrants — $11.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
EONREON Resources Inc$0.2430Last price
Private Placement Warrants (from 505,000 Private Placement Units) — $11.50
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
EONREON Resources Inc$0.2430Last price
Public Warrants (IPO units, EONR.WS) — $11.50 per whole share
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
VNTGVantage Corp$0.4420Last price
Representative's Warrants (IPO firm shares) — Network 1 Financial Securities, Inc., $5.00, issued 2025-06-13
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
VNTGVantage Corp$0.4420Last price
Representative's Warrants (over-allotment shares) — Network 1 and affiliates, $5.00, issued 2025-06-18
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.6M
ZEOZeo Energy Corp.$0.2140Last price
Assumed Heliogen SPAC Private Warrants (former Athena Technology Acquisition Corp. private placement warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.5M
ZEOZeo Energy Corp.$0.2140Last price
Assumed Heliogen SPAC Public Warrants (former Athena Technology Acquisition Corp. public warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.5M
ZEOZeo Energy Corp.$0.2140Last price
Public Warrants (ESGEN IPO warrants, Nasdaq: ZEOWW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$13.5M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 18, 2026.
Read from 2,083 dilution snapshots. 4,882 of 5,334 series state an exercise price and 3,363 an expiry date. 282 record when exercise begins; that count grows as companies are re-extracted. 628 series are left off because their figures could not be restated for a stock split. 19 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.